Financhill
Back

Tyra Biosciences Quote, Financials, Valuation and Earnings

Tyra Biosciences Price Quote

$15.96
-0.95 (-5.62%)
(Updated: October 30, 2024 at 6:55 PM ET)

Tyra Biosciences Key Stats

Sell
41
Tyra Biosciences (TYRA) is a Sell

Day range:
$16.30 - $20.50
52-week range:
$10.60 - $29.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.37%

Volume:
2.1M
Avg. volume:
391.4K
1-year change:
53.31%
Market cap:
$893M
Revenue:
$0
EPS:
$-1.69

How Much Does Tyra Biosciences Make?

Data Unavailable

Is Tyra Biosciences Growing As A Company?

Data Unavailable

Tyra Biosciences Stock Price Performance

  • Did Tyra Biosciences Stock Go Up Last Month?
    Tyra Biosciences share price went down by -27.55% last month
  • Did TYRA's Share Price Rise Over The Last Year?
    TYRA share price rose by 53.31% over the past 1 year

What Is Tyra Biosciences 52-Week High & Low?

Tyra Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Tyra Biosciences?

  • How Much Debt Does Tyra Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Tyra Biosciences Have?
    Cash and short term investments quarterly total is $373.8M
  • What Is Tyra Biosciences’s Book Value Per Share?
    Book value per share is 7.13

Is Tyra Biosciences Cash Flow Positive?

  • What Is TYRA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$63M
  • What Is Tyra Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $201.5M
  • What Is Tyra Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$271.4M

Tyra Biosciences Return On Invested Capital

Data Unavailable

Tyra Biosciences Earnings Date & Stock Price

Tyra Biosciences Competitors

  • Who Are Tyra Biosciences's Competitors?
    Below is a list of companies who compete with Tyra Biosciences or are related in some way:
    • Amgen Inc (AMGN)
    • iBio Inc (IBIO)
    • Johnson & Johnson (JNJ)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Tyra Biosciences Dividend Yield

Tyra Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 18.37%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 31.67
Upside from Last Price: 87.27%

Major Shareholders

  • How many TYRA shares are owned by institutional investors?
    69.5M TYRA shares are owned by institutional investors
  • How many TYRA shares are owned by insiders?
    3M TYRA shares are owned by insiders